Skip to main content
SpringerLink
Log in

Hepatitis C virus treatment: The beginning of a new era

  • Clinical Trials Report
  • Published:
Current HIV/AIDS Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Fried MW, Shiffman ML, Reddy KR, et al.: Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002, 347:975–982.

    Article  PubMed  CAS  Google Scholar 

  2. Torriani FJ, Rodriguez-Torres M, Rockstroh JK, et al.: Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med 2004, 351:438–450.

    Article  PubMed  CAS  Google Scholar 

  3. Hézode C, Forestier N, Dusheiko G, et al.: Telaprevir and peginterferon with or without ribavirin for chronic HCV infection. N Engl J Med 2009, 360:1839–1850.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Infectious Diseases, University of Pennsylvania, Philadelphia, USA

    Pablo Tebas

  2. 536 Johnson Pavilion, 36th Street and Hamilton Walk, Philadelphia, PA, 19104, USA

    Pablo Tebas

Authors
  1. Pablo Tebas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pablo Tebas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tebas, P. Hepatitis C virus treatment: The beginning of a new era. Curr HIV/AIDS Rep 6, 117–118 (2009). https://doi.org/10.1007/s11904-009-0023-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11904-009-0023-y

Keywords

Search

Navigation